Isoxazoline Market Analysis 2034: US$ 21.06 Billion Growth Trajectory
Growth rates above 14% are uncommon in healthcare. Yet the Isoxazoline Market is forecast to post a 14.45% CAGR from 2026 to 2034, rising from US$ 6.25 Billion in 2025 to US$ 21.06 Billion by 2034. Manufacturers and investors are watching this category closely. What Is Driving the Market? Pest control innovation is the first driver. Isoxazolines act quickly and last for weeks, which makes them...
0 Σχόλια 0 Μοιράστηκε 8 Views 0 Προεπισκόπηση